Cancer Family
Malignant Neoplasm
CI-CAN-00000025CAExplore in graph →
20,108 active trials259 approved drugs3,741 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000025CAExplore in graph →
Clinical trials
90,662 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (11,158)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01549548 | Compassionate Use Ponatinib | no longer available | — | — | OHSU Knight Cancer InstituteOTHER | 1 | Mar 15, 2013 | clinicaltrials |
| NCT01427582 | YONDELIS (Trabectedin) Single Patient Compassionate Use / Expanded Access | no longer available | — | — | University of Texas Southwestern Medical CenterOTHER | 1 | Sep 1, 2011 | clinicaltrials |
| NCT00302016 | Expanded Access Program of AMN107 in Imatinib-resistant or Intolerant Adult Patients With Chronic Myeloid Leukemia | no longer available | — | — | Novartis PharmaceuticalsINDUSTRY | 34 | Aug 26, 2011 | clinicaltrials |
| NCT00655252 | Expanded Access Study of RAD001 in Metastatic Renal Cell Cancer Patients Who Are Intolerant of or Who Have Failed Despite Prior Vascular Endothelial Growth Factor Therapy | no longer available | — | — | Novartis PharmaceuticalsINDUSTRY | 13 | Aug 19, 2011 | clinicaltrials |
| NCT00413270 | Oral Nilotinib in Adults With Chronic Myeloid Leukemia (CML) in Blast Crisis Who Are Imatinib Resistant or Intolerant | no longer available | — | — | Novartis PharmaceuticalsINDUSTRY | 1 | Jul 13, 2011 | clinicaltrials |
| NCT01279798 | Expanded Access Multicenter Study of Lucanix® (Belagenpumatucel-L) | no longer available | — | — | NovaRx CorporationINDUSTRY | 1 | Mar 1, 2011 | clinicaltrials |
| NCT01005537 | Cyclophosphamide, Autologous Lymphocytes, and Aldesleukin in Treating Patients With Metastatic Melanoma | no longer available | — | — | Fred Hutchinson Cancer CenterOTHER | 0 | Aug 6, 2010 | clinicaltrials |
| NCT00584493 | Treatment Use Study for Advanced Melanoma. | no longer available | — | — | PfizerINDUSTRY | 0 | Dec 14, 2009 | clinicaltrials |
| NCT00805337 | Low Levels of Electromagnetic Fields to Treat Advanced Cancer(ADLG3) | no longer available | — | — | Pasche, Boris, M.D.INDIV | 0 | Dec 9, 2008 | clinicaltrials |
| NCT00636259 | Casodex 150-mg Compassionate Use Trial for Subjects With Prostate Cancer | no longer available | — | — | AstraZenecaINDUSTRY | 0 | Jun 11, 2008 | clinicaltrials |
| NCT00517894 | Dose-Dense Therapy in Aggressive Lymphoma | no longer available | — | — | Arbeitsgemeinschaft medikamentoese TumortherapieOTHER | 0 | Aug 17, 2007 | clinicaltrials |
| NCT00063791 | A Study to Assess Two Different Strategies of Combining Dexamethasone and VELCADE | no longer available | — | — | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Feb 14, 2007 | clinicaltrials |
Data updated 22 days agoSource updated Mar 15, 2013source: clinicaltrials